Mediplantex National Pharmaceutical JSC (HNX:MED)

Vietnam flag Vietnam · Delayed Price · Currency is VND
20,400
0.00 (0.00%)
At close: Mar 31, 2026
-23.02%
Market Cap 253.16B
Revenue (ttm) 366.83B
Net Income (ttm) 15.83B
Shares Out 12.41M
EPS (ttm) 1,275.86
PE Ratio 15.99
Forward PE n/a
Dividend 1,200.00 (5.88%)
Ex-Dividend Date Jul 16, 2025
Volume 100
Average Volume 2,733
Open 20,400
Previous Close 20,400
Day's Range 20,400 - 20,400
52-Week Range 20,400 - 28,600
Beta -0.01
RSI 35.61
Earnings Date Apr 17, 2026

About HNX:MED

Mediplantex National Pharmaceutical Joint Stock Company produces and trades in pharmaceutical products in Vietnam. The company offers pharmaceutical products in various categories, including drugs from herbals; analgesics, corticosteroid, and anti-inflammatory drugs; antibiotics; cerebral circulation, heart, and lung drugs; anti-malarial, demostasis, gout, diabetes, allergies, and osteoarthritis drugs; acid amin, vitamins, and minerals; and other products. It also provides pharmaceutical chemicals and medicinal herbs; and extracting and semi sy... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 310
Stock Exchange Hanoi Stock Exchange
Ticker Symbol MED
Full Company Profile

Financial Performance

In 2025, HNX:MED's revenue was 366.83 billion, a decrease of -17.22% compared to the previous year's 443.14 billion. Earnings were 15.83 billion, an increase of 3.85%.

Financial Statements

News

There is no news available yet.